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Purpose: Ceria engineered nanomaterials (ENMs) have current commercial applications and 
both neuroprotective and toxic effects. Our hypothesis is that ceria ENMs can associate with 
brain capillary cells and/or cross the blood–brain barrier.
Methods: An aqueous dispersion of ∼5 nm ceria ENM was synthesized and characterized in 
house. Its uptake space in the Sprague Dawley rat brain was determined using the in situ brain 
perfusion technique at 15 and 20 mL/minute flow rates; 30, 100, and 500 µg/mL ceria perfused 
for 120 seconds at 20 mL/minute; and 30 µg/mL perfused for 20, 60, and 120 seconds at 20 mL/
minute. The capillary depletion method and light and electron microscopy were used to determine 
its capillary cell and brain parenchymal association and localization.
Results: The vascular space was not significantly affected by brain perfusion flow rate or 
ENM, demonstrating that this ceria ENM did not influence blood–brain barrier integrity. 
Cerium concentrations, determined by inductively coupled plasma mass spectrometry, were 
significantly higher in the choroid plexus than in eight brain regions in the 100 and 500 µg/mL 
ceria perfusion groups. Ceria uptake into the eight brain regions was similar after 120-second 
perfusion of 30, 100, and 500 µg ceria/mL. Ceria uptake space significantly increased in the 
eight brain regions and choroid plexus after 60 versus 20 seconds, and it was similar after 60 
and 120 seconds. The capillary depletion method showed 99.4% ± 1.1% of the ceria ENM 
associated with the capillary fraction. Electron microscopy showed the ceria ENM located on 
the endothelial cell luminal surface.
Conclusion: Ceria ENM association with brain capillary endothelial cells saturated between 20 
and 60 seconds and ceria ENM brain uptake was not diffusion-mediated. During the 120-second 
ceria ENM perfusion, ceria ENM predominately associated with the surface of the brain capillary 
cells, providing the opportunity for its cell uptake or redistribution back into circulating blood.
Keywords: ceria engineered nanomaterial, brain microvascular endothelial cell association, in 
situ brain perfusion, capillary depletion
Introduction
Commercial and scientific interest in ceria engineered nanomaterials (ENMs) has 
expanded rapidly in recent years. Numerous studies have found ceria to be neuropro-
tective, suggesting that it has utility in medical disorders caused by reactive oxygen 
species.1–6 In retinal neurons, 5 nm ceria ENM inhibited H
2
O
2
-induced reactive oxy-
gen species.7 Ceria ENMs enhanced spinal neuron viability 3 and protected a mixed 
culture of cortical neurons and glial cells from H
2
O
2
-induced injury.8 A protective 
effect of ceria ENMs on mouse hippocampal slices was demonstrated in a model of 
ischemia.5 Although these reports showed the therapeutic potential of ceria ENM as a 
neuroprotective agent, none has investigated the ability of ceria ENMs to associate with 
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and/or cross the blood–brain barrier (BBB). Other  studies 
have found that ceria ENMs can cause oxidative stress and 
induce toxicity.9–11 In light of the potential neuroprotective 
therapeutic applications and toxicity concerns of ceria ENMs, 
it is very important to understand their interaction with the 
BBB and brain parenchyma.
Brain capillary endothelial cells cooperate with pericytes, 
astrocytes, and neurons to generate and maintain the unique 
barrier properties of the BBB, which plays a crucial role 
in safeguarding the brain from endogenous and exogenous 
compounds circulating in the blood.12 Although the BBB is a 
tightly regulated barrier, ENMs are being extensively investi-
gated as an approach to deliver drugs to the central nervous 
system, based on their unique physicochemical properties, 
such as tight junction disruption, increased retention at the 
brain capillaries combined with adsorption to the capillary 
walls, and receptor-mediated transcytosis.13,14 Several studies 
have indicated that metal ENMs altered BBB integrity and 
increased its permeability, and/or led to toxicity to the BBB 
and the brain.15,16 The biodistribution of 15, 50, 100, and 
200 nm gold nanoparticles was investigated 24 hours after 
its intravenous (IV) administration. The 15 and 50 nm gold 
crossed the BBB and entered the brain; the larger ENMs did 
not.17 After oral gavage, 25 nm ceria appeared in the brain one 
day later and was still present in the brain on day 7.18 Although 
these studies indicated that some metal oxide ENMs have 
the potential to cross the BBB, most studies on brain ENM 
uptake did not separate the capillary endothelial cells from 
the brain cells, making it difficult to determine whether the 
ENMs entered the brain or if their distribution was limited 
to the capillary endothelial cells. More research is needed 
in order to understand the distribution of ENMs between 
capillary endothelial cells and/or brain tissue.
Our previous findings showed that 5 nm ceria ENM 
agglomerates in the brain capillary lumen. Electron micros-
copy (EM) did not reveal ceria ENM inside microvascular 
endothelial or brain cells. Ceria did not produce profound 
pro- or antioxidant effects in the brain one or 20 hours after 
a 1-hour systematic IV infusion.19 The reasons for the lack 
of ceria ENMs in the brain are unknown. One possibility is 
that the ceria ENMs were rapidly coated by proteins in the 
blood that changed their physicochemical properties, result-
ing in their rapid clearance by the mononuclear phagocyte 
system.20,21 Another possibility is that the nanoparticles 
agglomerated very rapidly in the blood or on a biological 
surface, changing their distribution and cell interaction,22–25 
so that the agglomerated ceria became too large or  unavailable 
to penetrate the intact BBB. The present study utilized a 
controlled system to better understand how ceria ENMs 
interact with brain capillary endothelial cells. The results are 
relevant to the therapeutic use and toxicological consideration 
of ceria ENMs.
The objective of this study was to investigate the brain 
capillary cell association and brain entry rate of a 5 nm 
ceria ENM. We used the in situ brain perfusion method to 
evaluate BBB integrity and determine brain entry rate at dif-
ferent perfusion flow rates, ceria ENM concentrations, and 
perfusion durations. Eight brain regions and a choroid plexus 
(ipsilateral to the perfusion) were collected to test regional 
differences in BBB integrity and ceria ENM brain entry 
rate. The capillary depletion method was used to evaluate 
ceria ENM distribution between capillary and brain tissues. 
Light microscopy (LM) and EM were used to investigate the 
localization of ceria nanoparticles.
Materials and methods
Nanomaterial
The 5 nm ceria ENM was synthesized using a previously 
reported method (supplementary materials).19 The physico-
chemical properties of the ceria ENMs were determined 
in our laboratories. All of the methods have been reported 
previously (supplementary material).26 Free cerium in the 
ceria ENM dispersion was removed by ultrafiltration, using 
3 kDa molecular weight cutoff regenerated cellulose cen-
trifugal filtration devices (Amicon Ultra-4; EMD Millipore, 
Billerica, MA). The 5 nm ceria (3.5 mL) was added to 
the Amicon Ultra filter unit. The unit was centrifuged at 
4800 g for 35 minutes to obtain 3 mL filtrate and 0.5 mL 
concentrated ceria ENM. The 3 mL filtrate (containing free 
cerium) was removed from the centrifuge tube, and 3 mL 
sodium citrate (0.17 M) solution was added to the filtra-
tion device to disperse the ceria ENM. After conducting 
this washing procedure three times, sodium citrate solu-
tion (3 mL; 0.17 M) was added to the filtration device, 
which was bath sonicated for 15 minutes to redisperse 
the ceria ENM. The Ce concentrations of the 5 nm ceria 
ENM dispersion and free cerium in the ultrafiltrate were 
analyzed by inductively coupled plasma mass spectrometry 
(ICP-MS).19,26
Perfusate for in situ brain perfusion
The perfusate contained 30, 100, or 500 µg/mL ceria ENM 
in a solution of Na+ (153 mM), K+ (4.2 mM), Ca2+ (1.5 mM), 
Mg2+ (0.9 mM), Cl– (162 mM), and glucose (9 mM). Gad-
olinium-diethylenetriamine pentaacetic acid (Gd-DTPA) 
(1 mM) was added to determine BBB integrity. It has been 
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shown that Gd-DTPA, a marker for vascular space, does 
not significantly cross the intact BBB, due to its charge and 
high molecular weight.27 A significant increase of Gd-DTPA 
in brain samples indicates BBB damage.  Following at least 
1-hour incubation at 37°C, the perfusate was bubbled for 
2 minutes with 95/5 air/CO
2
 and adjusted to pH 7.4 prior 
to its use.28
Ceria ENM stability in the perfusate
Ceria ENM stability in the perfusate was determined from 1 
to 230 minutes (after addition to perfusate) using dynamic 
light scattering (90Plus Nanoparticle Size Distribution 
 Analyzer; Brookhaven Instruments Corp, Holtsville, NY). 
The intensity-weighted hydrodynamic diameter in the 
 perfusate was measured at 1000 µg/mL at 37°C, and then it 
was converted to number- and volume-weighted averages.
Animals
In this study, 55 male Sprague Dawley rats were used, 
weighing 330 ± 35 g (mean ± standard deviation [SD]). 
Prior to the study, the animals were housed individually 
in the  University of Kentucky Division of Laboratory 
Animal Resources Facility. Animal work was approved by 
the University of Kentucky Institutional Animal Care and 
Use Committee (Protocol 2008-0272). The research was 
conducted in accordance with the Guiding Principles in the 
Use of Animals in Toxicology.
In situ brain perfusion methods
We employed the modification of the brain perfusion tech-
nique as previously reported.28–30 Briefly, the rat was anesthe-
tized under ketamine/xylazine anesthesia (75 and 5 mg/kg), 
and its left carotid artery was exposed. Following ligation of 
the external carotid, occipital, and common carotid arteries, 
PE60 tubing containing heparin (100 U/mL, in 0.9% NaCl) 
was inserted into the common carotid. We used the heart-cut 
modification of this technique and increased the perfusate 
flow rate to 20 mL/minutes.31 The rat was decapitated to end 
the perfusion, and the brain was harvested and cleaned of 
meninges and surface vessels. Brain tissue (∼20 mg from 
each brain region, except the choroid plexus, which aver-
aged 0.9 ± 0.4 mg) was collected from the frontal cortex, 
parietal cortex, occipital cortex, thalamus/hypothalamus, 
midbrain/colliculus, striatum, cerebellum, hippocampus, and 
choroid plexus, from the left hemisphere, for measurement 
of Gd-DTPA (as gadolinium) and ceria ENM (as cerium) 
by ICP-MS. Cerebrovascular washout of the perfusate was 
conducted to test the influence of ceria concentrations in the 
vascular space on the brain uptake space. The cerebrovascular 
space was washed at the same perfusion rate (n = 4 rats) for 
20 seconds, with ceria-free perfusate, immediately following 
100 µg ceria ENM/mL perfusion for 120 seconds at 20 mL/
minute. The results were compared to those obtained without 
cerebrovascular washout, using a two-way analysis of vari-
ance (ANOVA). The brain uptake space in the washout and 
nonwashout conditions did not show a significant difference 
after correcting for the vascular volume. Therefore, washouts 
were not conducted in the rest of the studies, except for the 
capillary depletion experiment, and three rats perfused for 
LM and EM examination.
Flow-rate-dependent uptake is a property of some 
carrier-mediated uptake systems, but it is not a property of 
diffusion.28 Therefore, to examine the effect of perfusion 
flow rate on influx rate and the vascular and brain extra-
cellular fluid volumes, 15 and 20 mL/minute flow rates 
(100 µg ceria ENM/mL) were tested in four and five rats, 
respectively. To determine whether ceria ENM brain entry 
is concentration-dependent, three ceria ENM concentra-
tions (30, 100, and 500 µg/mL) were investigated, using a 
perfusion rate of 20 mL/minute for 120 seconds (n = 4, 6, 
and 5 rats, respectively). Ceria ENM brain entry during the 
different perfusion durations was investigated to determine 
how fast ceria ENM associates with brain capillary cells or 
enters the brain. Perfusion durations of 20, 60, and 120 sec-
onds, using a rate of 20 mL/minutes and 30 µg ceria ENM/mL 
were studied in 4 treated animals and 3 control animals in 
each group. Three animals were prepared for LM and EM 
after perfusion with 100 µg ceria ENM/mL, 20 mL/minute 
for 120 seconds, followed by a 20-second washout with 
ceria-free perfusate.
Capillary depletion method
The capillary depletion method was used to separate brain 
parenchyma from capillary tissue.28,32 After a 30-µg/mL, 
120-second, 20-mL/minute ceria ENM  perfusion, a 20-second 
washout was conducted. The forebrain from the perfused 
hemisphere was isolated from 10 rats (2 control and 8 
treated), and the lateral ventricle choroid plexus in the per-
fused hemisphere was removed. The tissue was homogenized 
in 3.5 mL physiological buffer containing 141 mM NaCl, 
4 mM KCl, 2.8 mM CaCl
2
, 1 mM NaH
2
PO
4
, 1 mM MgSO
4
, 
10 mM glucose, and 10 mM HEPES at pH 7.4. Dextran 
(70,000 g/mol) was then added to 18% (w/v), and the sample 
was further briefly homogenized. After centrifugation at 
5400 x g for 15 minutes at 4 °C, the supernatant (brain-rich 
fraction) and pellet (capillary-rich fraction) were carefully 
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separated for measurement of ceria ENM by ICP-MS. The 
percentage of the forebrain ceria ENM in the capillary-
rich fraction = (mass amount of cerium in the capillary-
rich  fraction/mass amount of cerium in the capillary-rich 
 fraction + brain-rich fraction) × 100%. The percentage of the 
ceria ENM dose in the capillary rich fraction = (mass amount 
of cerium in the capillary-rich fraction/mass amount cerium 
in the total ceria ENM dose) × 100%.
Cerium and gadolinium analysis
Cerium and gadolinium were analyzed by ICP-MS 
 (Agilent 7500cx; Agilent Technologies, Santa Clara, CA), 
as  previously described.16,33 The method detection limits of 
Ce and Gd in tissue were 0.013 mg Ce/kg and 0.0004 mg 
Gd/kg.
Light and electron microscopy
The rats were decapitated at the end of the in situ washout 
perfusion for brain removal. After bisection, each hemi-
sphere was immediately immersed in a fixative contain-
ing 2% paraformaldehyde–2% glutaraldehyde in 0.1 M 
cacodylate buffer, for 24 hours at 4°C. Tissue samples 
from the pituitary gland, hippocampus, and choroid plexus 
were identified with the aid of a dissecting microscope and 
stored in 0.1 M cacodylate buffer. Samples were cut to 
approximately 3 mm3 before being dehydrated in ascend-
ing concentrations of ethanol and embedded in Araldite 
502 (Electron Microscopy Sciences, Hatfield, PA). After 
polymerization, the blocks were sectioned at a thickness of 
one micron and toluidine blue-stained for screening, and 
selected blocks were sectioned at a thickness of 80 nm for 
transmission electron microscopy viewing with a Philips 
CM 10 electron microscope, (FEI Company, Hillsboro, OR), 
operated at 80 kV.
Data and statistical analysis
The distribution volume, or uptake space (Q), derived from 
the in situ brain perfusion results, is the amount of brain tissue 
into which the substrate distributes during a given perfusion 
duration. Q
ceria total
 (mL/g) = ceria ENM in tissue (µg/g)/ceria 
per volume of perfusate (µg/mL).34 The mass amount of 
ceria ENM per gram of brain (µg/g) was also calculated, in 
order to compare the results of perfusion of the three ceria 
ENM concentrations. Gd-DTPA uptake space (vascular 
plus extracellular space) was used to correct the ceria ENM 
brain uptake space results.28 Q
Gd-DTPA
 = Gd-DTPA in tissue 
(µg/g)/ Gd-DTPA  per volume of perfusate (µg/mL).  Corrected 
brain Q
ceria ENM
 = Q
ceria total
 – Q
Gd-DTPA
. The corrected mass 
amount of ceria ENM per gram of brain (µg/g) = (Q
ceria total
 – 
Q
Gd-DTPA
) (mL/g) × ceria per volume of perfusate (µg/mL). 
Grubbs’ test was used to determine outliers. Two-way 
ANOVA, followed by Bonferroni multiple comparisons, was 
used to test for significant differences among the three con-
centration groups and nine different regions (GraphPad Prism 
Version 3.00 for Windows; GraphPad Software, San Diego, 
CA). The percentage of the capillary surface area that would 
be covered by ceria ENMs was calculated as = (number of 
ceria ENM particles in the perfused hemisphere × cross-
sectional area of a ceria particle) × 100%/rat brain capillary 
endothelial cell surface area. This was based on the ceria 
average diameter, the ceria density = 7.132 g/cm3, and the 
rat’s capillary surface area = 140 cm2/g brain.35 All results 
are reported as mean ± SD.
Results
Nanoparticle characterization
The ceria ENM was polyhedral, and the X-ray diffraction 
pattern showed the ceria to be highly crystalline. It was 
face-centered cubic, with corresponding Miller indices of the 
most common faces of (111), (220), and (311). Evaluation 
of a number of transmission electron microscopy images 
 (Figure 1A) showed that D
mean
 (average primary particle 
diameter from number frequency distribution) and standard 
deviation based on transmission electron microscopy mea-
surements of diameter fitted using lognormal distribution 
models was 4.6 ± 0.1 nm. Dynamic light scattering results 
of a representative batch of ceria dispersion showed that 98% 
of the particles were in the range of 6.7–8.2 nm (Figure 1B). 
Zeta potential was −53 ± 7 mV at pH ∼7.35 in water.
The ceria ENM surface area was 121 m2/g. The extent of 
surface citrate coating was ∼40%;19 5% free cerium ions were 
in the ceria ENM. After the three  filtrations, less than 0.05% 
of the ceria ENM perfusate was free cerium ions. Ceria ENM 
was stable in the perfusate at 37°C; no apparent agglomera-
tion was observed from 1 to 230 minutes. The particle size 
of the ceria ENMs was within ±1 SD after addition of the 
ceria ENM to the perfusate  (Figure 2). In this experiment, 
the stability of the ceria ENM in the perfusate is crucial for 
understanding how the ceria ENM interacts with capillary 
cells and brain tissue.
Flow rate dependency
Comparison of uptake space (Q
ceria ENM
) using 15 and 20 mL/
minute flow rates did not show a significant flow rate effect 
on brain ceria ENM uptake in any of the eight brain regions 
or the choroid plexus. Furthermore, there was no significant 
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Figure 1 Ceria ENM morphology. (A) Ceria ENM imaged using TEM. The insert at the top right shows the crystallinity of the ceria ENM. (B) Volume-based particle size 
distribution for ceria ENM of a representative batch of ceria aqueous dispersion.
Abbreviations: ENM, engineered nanomaterial; TEM, transmission electron microscopy.
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Figure 2 Ceria ENM hydrodynamic diameter in perfusate. hydrodynamic diameter (intensity weighted average) of ceria ENM in the in situ perfusate, from 1 to 230 minutes 
(1000 µg/mL at 37°C) after ceria was added to the perfusate.
Notes: Solid circles are DLS data; black solid line is the average of all the data. Dotted lines represent the average diameter ± 1 SD.
Abbreviations: ENM, engineered nanomaterial; DLS, dynamic light scattering; Dmean, diameter mean.
difference in the vascular space with these two flow rates or 
between the control and treated groups. However, the choroid 
plexus showed a significantly higher vascular space than the 
eight brain regions (Figure 3). The brain vascular space results 
were similar to those we measured using [14C]-sucrose.28 
A 20 mL/min flow rate was used for the rest of study.
Ceria ENM uptake
To investigate the 5 nm ceria brain entry rate, its uptake space 
(Q
ceria ENM
) was determined for each brain region for each of 
the three ceria perfusate concentrations. Figure 4A shows that 
the uptake space significantly decreased with the increase of 
ceria ENM concentration in the perfusate. In the 30 µg/mL 
group, there were no significant differences among the nine 
regions. However, in the 100 and 500 µg/mL groups, choroid 
plexus uptake space was significantly higher than in the eight 
brain regions. In order to compare ceria ENM uptake among 
the three concentrations, we calculated the mass amount 
of ceria uptake into the brain as µg/g  (Figure 4B). There 
were no significant differences among the three treatment 
concentrations. The mass amount of ceria in the choroid 
plexus uptake space was significantly higher than in the eight 
brain regions, and it was significantly higher in the 100 and 
500 µg/mL groups than in the 30 µg/mL group. The average 
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mass amount of ceria per brain hemisphere (0.85 g,  excluding 
choroid plexus) was 4.2 ± 0.7 µg. To verify whether the 
uptake space of ceria ENM rapidly saturates, ceria uptake 
space was determined for 30 µg ceria ENM/mL for 20-, 60-, 
and 120-second perfusion durations. There were significant 
increases of uptake space to multiple brain regions from 20 to 
60 seconds, but no differences between 60 and 120 seconds, 
suggesting that the uptake space of this ceria ENM saturated 
between 20 and 60 seconds  (Figure 4C). The increased 
uptake space of the 5 nm ceria ENM showed that the ceria 
ENM either associated with capillary endothelial cells or 
entered the brain. In the next step, ceria ENM distribution 
between cerebral capillary cells and brain parenchyma was 
determined.
Isolation of cerebral capillaries
Cerebral capillaries were isolated from brain parenchyma to 
investigate the distribution of ceria ENM between these two 
fractions. Less than 0.4% of the perfused ceria ENM dose was 
associated with cerebral capillaries and brain parenchyma. 
This separation revealed that a great majority of the ceria 
ENM (99.4% ± 1.1% of the total ceria ENM in the capillary-
rich fraction plus brain-rich fraction) was associated with 
the capillary endothelial cells. Less than 0.003% of the ceria 
ENM dose was associated with the brain-tissue-rich fraction 
(Figure 5). These results suggest that most of the 4.2 ± 0.7 µg 
ceria ENMs in the perfused brain hemisphere were associated 
with the capillary endothelial cells, and very little ceria ENM 
passed through the endothelial cells into brain extracellular 
fluid or brain cells.
Ceria ENM localization using LM and EM
Light and electron microscopy were used to confirm BBB 
integrity and determine the localization of ceria ENM in the 
endothelial cells and/or brain parenchyma. Light microscopy 
examination of the choroid plexus revealed the presence 
of a cuboidal epithelial cell layer surrounding a core of 
capillaries, with some surrounding loose connective tissue. 
There appeared to be no physical injury from exposure to 
the high perfusate flow rate (Figure 6A). A capillary in the 
mid-CA1 region of the hippocampus is shown in Figure 6B. 
The pyramidal cells appear unaffected by in situ perfusion. 
In the posterior pituitary, capillaries were not affected by the 
high perfusate flow rate (Figure 6C).
At the ultrastructural level, the endothelial lining of the 
choroid plexus appeared intact (Figure 7A). The adjacent 
ependymal cell layer was lined by tightly adhering cells 
with well-developed surface microvilli creating frond-like 
processes projecting into the ventricles. Consistent with the 
high ceria concentration in the choroid plexus, electron-dense 
ceria ENM agglomerations were observed on the endothelial 
lining (Figure 7A). Meanwhile, electron-dense nonagglomer-
ated ceria ENM particles adhered to the endothelial lining in 
the hippocampal vessels (Figure 7B) and the pituitary gland 
vessels that lacked a BBB (Figure 7C). Ceria ENM associ-
ated with the surface of brain capillary endothelial cells. 
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Figure 4 Ceria ENM uptake space at three concentrations and perfusion duration times. Effect of ceria ENM concentration and perfusion duration on its uptake. (A) Q uptake 
space (mL/g) of a 5 nm ceria ENM in eight brain regions and the choroid plexus for three concentrations, at a flow rate of 20 mL/minute, and 120-second perfusion duration. 
(B) Mass amount (µg/g) of 5 nm ceria ENM in eight brain regions and the choroid plexus after brain perfusion with three ceria concentrations, at a flow rate of 20 mL/minute 
and perfusion duration of 120 seconds. (C) Q uptake space (mL/g) of 5 nm ceria ENM in eight brain regions and choroid plexus after 20-, 60-, and 120-second perfusion at 
30 µg/mL, at a flow rate of 20 mL/minute.
Notes: (A) #Significantly different among three concentration groups, P , 0.05; *significantly different compared to the eight brain regions at the same concentration, 
P , 0.05. (B) #Significantly different compared to 30 µg/mL concentration group; *significantly different compared to the eight brain regions, P , 0.05. (C) #Significantly 
different between 20- and 60-second perfusion duration groups, P , 0.05.
Abbreviation: ENM, engineered nanomaterial.
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Figure 5 Capillary depletion results. The percentage of the ceria ENM dose in the 
capillary-rich fraction and brain-rich fraction for 100 µg/mL, at a flow rate of 20 mL/
minute, 120-second perfusion duration, followed by 20-second washout.
Abbreviation: ENM, engineered nanomaterial.
Figure 6 The capillaries in the (A) choroid plexus, (B) hippocampus (mid-CA1 region), and (C) pituitary were not affected by the high perfusate flow rate.
Note: Rats were perfused with 100 µg ceria ENM/mL, at a flow rate of 20 mL/minute, and perfusion duration of 120 seconds.
Abbreviation: ENM, engineered nanomaterial.
No ceria ENM was observed in any brain parenchyma, con-
sistent with our capillary depletion results. The ultrastructural 
data lend support to the calculation that 2.4% ± 0.4% of the 
luminal surface area of the capillary endothelial cells would 
be occupied by the 4.2 ± 0.7 µg ceria ENM per hemisphere 
measured in our uptake study.
Discussion
The results demonstrate that this ceria ENM did not influ-
ence BBB integrity. Perfusate flow rate and ceria ENM 
concentration did not influence ceria ENM uptake into 
brain parenchyma, providing evidence of a non-diffusion 
mechanism. The uptake space of the 5 nm ceria ENM did 
increase, compared to the vascular space, leading to the 
conclusion that the 5 nm ceria ENM either associated with 
capillary endothelial cells or entered the brain. The capil-
lary depletion method showed that most of the ceria ENM 
associated with the capillary cells. Association of the ceria 
with the brain endothelial cells was a very rapid process that 
saturated between 20 and 60 seconds using a flow rate of 
20 mL/minute and ceria ENM concentration of 30 µl/mL. 
Electron microscopy revealed that the ceria ENM associated 
with the capillary luminal wall, and it was not seen inside 
the brain capillary endothelial cells.
Prior to recent studies, how metal- or metal oxide-ENMs 
interact with or cross the brain capillary endothelial cells was 
poorly understood. One of the issues relevant to how nano-
materials interact with biological membranes is that “what 
the cell sees” may not be the same as the ENM introduced 
into the study preparation (eg, cells in culture, intact mammal 
in this study). Several researchers have shown that ENMs 
agglomerate in cell culture media.9,22 In blood, plasma pro-
teins rapidly adsorb to nanoparticle surfaces to form a protein 
corona that can change the physicochemical properties and 
influence the fate of ENMs.20,36,37 It is difficult to interpret 
some in vitro and in vivo nanoparticle studies, due to their 
agglomeration in cell culture media and development of the 
protein corona in blood. In our studies, we used a technique 
that does not allow the nanoparticles to mix with blood. We 
determined the size distribution and stability of our ceria 
ENM in the perfusate from 1 to 230 minutes. The results did 
not show agglomeration, which was supported by EM images 
that did not show significant ceria ENM agglomeration in 
the rat brain. This is the first report of ceria ENM interaction 
with the BBB, in vivo, under conditions that control ENM 
chemistry. This research helps us to understand citrate-coated 
5 nm ceria brain capillary cell association, potential brain 
entry, and redistribution. The in situ brain perfusion tech-
nique is a good experimental method by which to investigate 
how physicochemical properties influence the interaction 
of ENMs with, or their crossing of, the BBB in the absence 
of major agglomeration and a protein corona. The research 
helps us understand how certain physicochemical properties 
influence the ability of ENMs to associate with or cross the 
BBB for therapeutic application.
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Our results showed that most of the ceria ENMs were 
associated with brain capillary cells rather than brain cells. 
 Several studies reported that metal- and metal oxide-ENMs 
cross the BBB.15,16,38,39 Without separating brain capillary cells 
from brain cells, it is very possible that the ENMs in those 
studies were associated with endothelial cells rather than 
entering brain parenchyma. For example, based on ICP-MS 
results of brain metal content, bovine serum albumin-coated 
silver-ENM was found in the brain, compared with the con-
trol. Signs of silver-induced brain damage were observed; 
however, EM did not reveal silver-ENMs in the brain.40 It 
is possible that the silver-ENMs associated with the BBB 
and released silver ions to produce the toxicity, rather than 
being an effect of silver-ENMs. A previous study using the 
in situ brain perfusion method reported that polymer-based 
nanoparticles entered the central nervous system within 
60 seconds, without influencing BBB integrity. However, 
the researchers did not separate the capillary cells from the 
brain parenchyma. They showed an uptake space similar to 
results we obtained at 20 and 60 seconds. Capillary associa-
tion also may contribute to their brain uptake space.41 Our 
previous studies showed only 0.02% of a 5 nm ceria dose 
in the brain 1 hour after IV infusion. However, we did not 
observe any 5 nm ceria ENM in the brain tissue.19 In light of 
the results in this paper, the 0.02% ceria in the brain may be 
ceria ENM in blood and associated with capillary cells. In 
this study, brain association (0.383% of the ceria ENM dose) 
using in situ perfusion is 19 times higher than our previous 
report of ceria ENM in the brain (0.02% of the ceria dose) 
1 hour after IV infusion. The different timelines (in the prior 
study, brain samples were obtained 1 hour after completion 
of ceria infusion; in the present study, the samples were 
obtained immediately after completion of ceria perfusion) 
and routes (IV versus intra-carotid artery) contributed to the 
differences in brain ceria ENM. In the present study using 
in situ brain perfusion, ceria ENM did not mix with blood 
and avoided first-pass clearance. After IV administration, 
ceria ENM agglomerated in the blood, and protein corona 
formation changed its physicochemical properties, resulting 
in rapid clearance by the mononuclear phagocyte system.21,26 
Ceria ENM may associate with brain capillary cells during a 
120-second perfusion and dissociate later. The above reasons 
may explain the high brain capillary/ceria ENM association, 
compared with our previous IV infusion study.
Our EM results showed that most of the ceria ENM is 
on the luminal surface of brain capillary cells rather than 
inside these cells. Brain capillary cell association with 
this negatively charged ceria ENM is in agreement with a 
previous kinetic study that reported a negatively charged 
nanoparticle associated with the cell surface, within seconds, 
by Langmuir adsorption through electrostatic interaction.42 
After surface adsorption, the next step may be dissociation 
and redistribution or cell internalization. The time course of 
cell internalization of metal oxide nanoparticles is still under 
investigation. Anionic iron oxide-ENMs attached onto the cell 
membrane of HeLa cells immediately after ENM introduction 
to the cells. Early endocytic-coated vesicles were observed at 
10 minutes.42 Most of the literature we are aware of showed 
cell line- and material-dependent ENM internalization half 
lives of more than a few minutes in vitro and in vivo.42–46 In 
three different cancer cells, 14, 50, and 74 nm gold nano-
particles had uptake half-lives of more than 1 hour.43 Flux 
of cationic arginine–vasopressin nanoparticles across the 
BBB started at 15 minutes through absorptive-mediated 
endocytosis in mice.45 Because of the nature of the in situ 
perfusion technique, perfusion duration in the present study 
was not greater than 120 seconds.34 More research is needed 
to understand what happens after the ceria ENMs interact 
with brain capillary cells. However, no matter what does 
happen, it is very important to know the rate and extent of 
cell surface adsorption, as it is the initial step for ENM cell 
uptake and potential redistribution back into the blood.
In this study, capillary depletion results showed ceria 
ENM associated with brain endothelial cells. Electron 
Figure 7 (A) A capillary with intact endothelial lining in the choroid plexus containing two ceria ENM agglomerates (arrows). (B) A vessel in the hippocampus and 
(C) a vessel from the pituitary gland associated with fine ceria ENM (arrows).
Note: Rats were perfused with 100 µg ceria ENM/mL, at a flow rate of 20 mL/minute, and perfusion duration of 120 seconds.
Abbreviation: ENM, engineered nanomaterial.
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microscopy failed to find any 5 nm ceria in brain parenchyma; 
however, nonagglomerated ceria ENM was observed to 
associate with the luminal wall of brain capillary endothelial 
cells. Assuming that all of the ceria associated with the cap-
illary surface without any agglomeration, and based on the 
mass of ceria ENM we observed in the rat brain after arterial 
ceria ENM perfusion, our calculation showed that 2.4% ± 0.4% 
of the brain capillary surface area might be covered by the 
ceria ENM. We think that the 4.2 ± 0.7 µg of ceria ENM per 
brain hemisphere seen in the present study might contribute 
to ceria ENM redistribution or sustained release back into 
the blood. Ceria ENM dissociation from the brain capillary 
luminal wall over time may provide an explanation for find-
ings in our pharmacokinetic study, wherein the circulating 
blood level of two sizes of ceria ENMs increased from 2 to 
4 hours after completion of their IV infusion, which cannot 
be explained using conventional pharmacokinetics.26 A simi-
lar increase of ENM in blood within the first 2 hours after 
its IV administration has been reported for quantum dots; 
however, explanation of the increase was not discussed in 
these reports.47,48 ENMs that associate with, and subsequently 
disassociate from, the vascular wall might provide an 
 explanation. Another study showed that 100–200 nm ceria 
ENMs (primary size, 3–5 nm) were observed on the luminal 
surface of mouse tail veins 30 days post-IV injection.49 It is 
not known if these agglomerated ceria nanoparticles were 
from original association with the blood vessel or from redis-
tribution over time. In general, our results showed that ENMs 
can associate with capillary cells, which may contribute to 
nanoparticle redistribution back into the blood.
This is the first study to report that a ceria ENM has a 
higher concentration in the choroid plexus compared with 
brain regions. Our vascular space results, measured by Gd-
DTPA, showed that the choroid plexus has a larger vascular 
space than brain tissues. The choroid plexus showed a sig-
nificantly higher uptake space compared with brain regions 
in the 100 and 500 µg/mL concentration groups, but not in 
the 30 µg/mL group. The choroid plexus uptake space did 
not change between the 100 and 500 µg/mL groups. Little 
is known about how metal oxide nanoparticles interact with 
the choroid plexus. The choroid plexus has larger surface 
area per mass, a leakier epithelial barrier, and different 
tight junction proteins and transport protein expression 
compared to cerebral endothelium.50,51 The fundamental 
differences between the choroidal epithelium and the cere-
bral endothelium may influence the ceria ENM association 
sites and determine the ceria ENM saturation concentration. 
Ceria agglomerates (Figure 7) were observed in the choroid 
plexus, compared to primary fine ceria ENM on the surface 
of the brain endothelial cells, providing evidence that ceria 
ENM may associate with the choroid plexus differently than 
the BBB, leading to higher concentrations in the choroid 
plexus. Previous research showed that the choroid plexus 
sequesters metal ions rapidly, and that their concentrations 
were more than ten times higher than other brain regions.28,52 
Some polymer nanoparticles showed similar results as the 
present study. Poly (d,l-lactide-co-glycolide) nanoparticles 
showed a high concentration in the choroid plexus.53 The 
choroid plexus is considered a potential region to retain 
nanoparticles,54 and a pathway to enter the central ner-
vous system.51,55 Our results provide the first evidence that 
ceria ENMs interact significantly with the choroid plexus; 
this information is very important for toxicity concerns and 
therapeutic applications.
Conclusion
Brain uptake of a 5 nm ceria ENM was flow rate- and 
perfusion concentration-independent, showing that 
diffusion was not mediating its association with brain tissue. 
The ceria ENM concentration was significantly higher in the 
choroid plexus than in eight brain regions. Brain ceria ENM 
association was a very rapid process that reached saturation 
between 20 and 60 seconds. The capillary depletion method 
showed that the ceria ENM was predominantly associ-
ated with the brain capillary cells rather than with brain 
parenchyma. Furthermore, EM showed that most of the 
ceria ENM associated with the luminal surface of brain 
endothelial cells, rather than entering the cells. This research 
provides the first data on the kinetics of ceria ENM interac-
tion with the BBB and choroid plexus. Ceria ENM capillary 
cell surface association also provides a site from which it 
can dissociate, redistribute, or enter the capillary cells. 
This information will be important for the design of ceria 
ENMs as a therapeutic agent, as well as for a comprehensive 
toxicology assessment.
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Supplementary materials
Materials and methods 
Materials
The chemicals used to prepare the ceria engineered 
nanomaterials (ENMs) have been described.1 Cerium chlo-
ride heptahydrate (#228931, 99.9% metal basis; Sigma-
Aldrich, St Louis, MO), ammonium hydroxide (Thermo 
Fisher Scientific, Waltham, MA; #3256, ACS, 28%–30%), 
deionized ultra filtered water (Thermo Fisher Scientific; 
#W2-20), and citric acid monohydrate (EMD Millipore, 
Billerica, MA; #CX1725-1, GR ACS) were used without 
further purification. All other chemicals were purchased from 
Sigma-Aldrich unless otherwise noted.
Ceria ENM synthesis 
Synthesis of the 5 nm ceria ENM was described.2 It was 
synthesized using a hydrothermal method3 that produces 
monodisperse nanoparticles directly in the reactor.  Typically, 
a 20 mL aqueous mixture of 0.5 M (0.01 mol) cerium chloride 
and 0.5 M (0.01 mol) citric acid was added to 20 mL of 3 M 
ammonium hydroxide. The latter was in excess of what was 
needed for complete reaction of the cerium chloride to cerium 
hydroxide. After stirring for 24 hours at 50°C, the solution 
was transferred to a Teflon-lined, stainless steel bomb, and 
heated at 80°C for 24 hours to complete the reaction. The 
ceria ENMs were citrate coated (capped) to improve their 
dispersity in water to stabilize dispersion through electrostatic 
repulsion and prevent the agglomeration seen with uncoated 
ceria that occurs in high ionic strength solutions, such as 
blood.4–6 Citrate was selected because: it is a commonly used 
surface coating agent for ENMs to inhibit agglomeration 
(eg, National Institute of Standards of Technology refer-
ence materials 8011, 8012, and 8013 [NIST, Gaithersburg, 
MD]); it is a component of blood (present at ~100 µM in 
humans); it might coat bare ENMs circulating in blood; it 
has been shown to have no effect on erythrocyte response 
to silver-ENMs; and citrate-coated ENMs interact strongly 
with proteins, resulting in the rapid opsonization that occurs 
when ENMs enter blood.7–9 
Ceria ENM characterization
The physicochemical properties of the ceria ENMs were 
determined in our laboratories. Most of the methods have 
been reported.1 Primary particle size distributions were 
determined by transmission electron microscopy (TEM) 
and scanning transmission electron microscopy (200-keV 
field emission analytical transmission electron microscope, 
JEM-2010F; JEOL, Tokyo, Japan). From the individual 
primary particle sizes measured from TEM images, number 
frequency cumulative distributions were constructed. These 
cumulative distributions were best described by log-normal 
distribution models, characterized by a sample mean and its 
standard deviation. All of these data sets were well described 
by a single monomodal distribution; that is, one continuous 
distribution was observed, and no significant secondary or 
tertiary peaks were noted. The reported average diameter 
of each sample was D
ave
 = exp (µ), where µ is the mean of 
the log-normal probability distribution and the reported 
standard deviation is the value from the fit of the log-normal 
distribution to the data. For each sample, number-based 
differential frequency distributions were constructed using 
the model coefficients. The particle size distributions for 
each batch of as-synthesized ceria aqueous dispersion were 
determined using dynamic light scattering (DLS; 90Plus 
 NanoParticle Size Distribution Analyzer; Brookhaven 
Instruments  Corporation, Holtsville, NY). Zeta poten-
tial of the ceria dispersion as infused into the rat was 
estimated from electrophoretic mobility measurements, 
using a Zetasizer nanoZS with a typical ceria concen-
tration ~0.02 wt% (Malvern Instruments, Worcester-
shire, UK). Because the particles had hydrodynamic 
diameters < 200 nm, the Hückel approximation was used 
to calculate zeta potential from electrophoretic mobil-
ity. The surface area of the dried powder was determined 
using a Brunauer–Emmett–Teller surface area analyzer 
(Micromeritics Instrument Corporation, Norcross, GA). 
Thermogravimetric analysis (TGA7 Analyzer; PerkinElmer, 
Waltham, MA) was then performed to investigate the 
weight loss of citrate-coated ceria nanoparticles (NPs) 
over a 150°C–300°C temperature range, during which 
decomposition of citric acid occurs. The extent of citrate 
surface coating was estimated based on the assumption that 
all the ceria NPs were spherical and of uniform size.
References
1. Dan M, Wu P, Grulke EA, Graham UM, Unrine JM, Yokel RA. 
 Ceria-engineered nanomaterial distribution in, and clearance from, blood: 
size matters. Nanomedicine (Lond). 2012;7(1):95–110.
2. Hardas SS, Butterfield DA, Sultana R, et al. Brain distribution and toxi-
cological evaluation of a systemically delivered engineered nanoscale 
ceria. Toxicol Sci. 2010;116(2):562–576.
3. Masui T, Hirai H, Imanaka N, Adachi G, Sakata T, Mori H. Synthesis of 
cerium oxide nanoparticles by hydrothermal crystallization with citric 
acid. J Mater Sci Lett. 2002;21(6):489–491.
4. Xia T, Kovochich M, Liong M, et al. Comparison of the mechanism 
of toxicity of zinc oxide and cerium oxide nanoparticles based on 
dissolution and oxidative stress properties. ACS Nano. 2008;2(10): 
2121–2134.
submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
4035
Ceria engineered nanoparticle association with the blood–brain barrier
International Journal of Nanomedicine
Publish your work in this journal
Submit your manuscript here: http://www.dovepress.com/international-journal-of-nanomedicine-journal
The International Journal of Nanomedicine is an international, peer-
reviewed journal focusing on the application of nanotechnology 
in diagnostics, therapeutics, and drug delivery systems throughout 
the biomedical field. This journal is indexed on PubMed Central, 
MedLine, CAS, SciSearch®, Current Contents®/Clinical Medicine, 
Journal Citation Reports/Science Edition, EMBase, Scopus and the 
Elsevier Bibliographic databases. The manuscript management system 
is completely online and includes a very quick and fair peer-review 
system, which is all easy to use. Visit http://www.dovepress.com/ 
testimonials.php to read real quotes from published authors.
International Journal of Nanomedicine 2012:7
5. Cao T, Yang T, Gao Y, Yang Y, Hu H, Li F. Water-soluble NaYF4:Yb/Er 
upconversion nanophosphors: synthesis, characteristics and application 
in bioimaging. Inorg Chem Commun. 2010;13(3):392–394.
6. Frasca G, Gazeau F, Wilhelm C. Formation of a three-dimensional mul-
ticellular assembly using magnetic patterning. Langmuir. 2009;25(4): 
2348–2354.
7. Brewer SH, Glomm WR, Johnson MC, Knag MK, Franzen S. Probing 
BSA binding to citrate-coated gold nanoparticles and surfaces. Langmuir. 
2005;21(20):9303–9307.
8. Choi J, Reipa V, Hitchins VM, Goering PL, Malinauskas RA. 
 Physicochemical characterization and in vitro hemolysis evaluation of 
silver nanoparticles Toxicol Sci. 2011;123(1):133–143.
 9. Viota JL, Rudzka K, Trueba Á, Torres-Aleman I, Delgado ÁV.  Electrophoretic 
characterization of insulin growth factor (IGF-1)  functionalized magnetic 
nanoparticles. Langmuir. 2011;27(10):6426–6432.
 10. Packer AP, Lariviere D, Li C, et al. Validation of an inductively coupled 
plasma mass spectrometry (ICP-MS) method for the determina-
tion of cerium, strontium, and titanium in ceramic materials used in 
radiological dispersal devices (RDDs). Anal Chim Acta. 2007;588(2): 
166–172.
 11. Yokel RA, Florence RL, Unrine JM, et al. Biodistribution and oxidative 
stress effects of a systemically-introduced commercial ceria engineered 
nanomaterial. Nanotoxicology. 2009;3(4):234–248.
submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
Dovepress
4036
Dan et al
